1. Home
  2. FGEN vs SIDU Comparison

FGEN vs SIDU Comparison

Compare FGEN & SIDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • SIDU
  • Stock Information
  • Founded
  • FGEN 1993
  • SIDU 2012
  • Country
  • FGEN United States
  • SIDU United States
  • Employees
  • FGEN N/A
  • SIDU N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • SIDU Telecommunications Equipment
  • Sector
  • FGEN Health Care
  • SIDU Telecommunications
  • Exchange
  • FGEN Nasdaq
  • SIDU Nasdaq
  • Market Cap
  • FGEN 33.5M
  • SIDU 30.0M
  • IPO Year
  • FGEN 2014
  • SIDU 2021
  • Fundamental
  • Price
  • FGEN $7.80
  • SIDU $2.01
  • Analyst Decision
  • FGEN Strong Buy
  • SIDU
  • Analyst Count
  • FGEN 1
  • SIDU 0
  • Target Price
  • FGEN $250.00
  • SIDU N/A
  • AVG Volume (30 Days)
  • FGEN 56.2K
  • SIDU 667.8K
  • Earning Date
  • FGEN 08-05-2025
  • SIDU 08-18-2025
  • Dividend Yield
  • FGEN N/A
  • SIDU N/A
  • EPS Growth
  • FGEN N/A
  • SIDU N/A
  • EPS
  • FGEN N/A
  • SIDU N/A
  • Revenue
  • FGEN $6,996,000.00
  • SIDU $3,860,985.00
  • Revenue This Year
  • FGEN N/A
  • SIDU $144.49
  • Revenue Next Year
  • FGEN N/A
  • SIDU N/A
  • P/E Ratio
  • FGEN N/A
  • SIDU N/A
  • Revenue Growth
  • FGEN N/A
  • SIDU N/A
  • 52 Week Low
  • FGEN $4.50
  • SIDU $1.14
  • 52 Week High
  • FGEN $38.25
  • SIDU $7.65
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 67.08
  • SIDU 66.78
  • Support Level
  • FGEN $7.03
  • SIDU $1.71
  • Resistance Level
  • FGEN $5.73
  • SIDU $2.05
  • Average True Range (ATR)
  • FGEN 0.57
  • SIDU 0.11
  • MACD
  • FGEN 0.35
  • SIDU 0.03
  • Stochastic Oscillator
  • FGEN 100.00
  • SIDU 97.44

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

About SIDU Sidus Space Inc.

Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.

Share on Social Networks: